Drug Pricing Blog
Data-driven analysis of prescription drug costs, powered by CMS Medicare data and FDA patent records.
How Drug Pricing Works in America: The Complete Guide
The definitive guide to WAC, AWP, NADAC, PBMs, and the entire drug pricing supply chain. Understand why your prescription costs what it does.
GLP-1 Pricing Guide 2026: Ozempic vs Wegovy vs Mounjaro vs Zepbound
Compare costs for every GLP-1 drug. Medicare negotiated prices, compounded alternatives, TrumpRx discounts, and how to save.
TrumpRx vs GoodRx vs Cost Plus Drugs: Which Saves You More?
Head-to-head comparison of the three major drug discount programs. Coverage, pricing models, and when to use each.
Medicare Drug Price Negotiation Explained: How the IRA Is Cutting Drug Costs
How the Inflation Reduction Act lets Medicare negotiate prices for 25 drugs, with discounts of 30-80%. Complete list and timeline.
The Patent Cliff: $230 Billion in Drug Savings Coming by 2030
Major drugs losing patent protection 2025-2030. When generics launch for Januvia, Eliquis, Keytruda, and more.
The Cheapest Prescription Drugs by Class: A Complete Price Guide
Find the lowest-cost option for statins, blood pressure meds, antidepressants, diabetes drugs, and more.
Biosimilars Explained: The Generic Revolution for Biologic Drugs
What biosimilars are, how they save money, and the current landscape: 22 Humira biosimilars, 9 Stelara biosimilars, and more.
PBM Transparency: Where Your Drug Dollar Goes
How pharmacy benefit managers control 80% of prescriptions, profit from spread pricing, and why reform is coming in 2028.
Most Expensive Prescription Drugs in America 2026
The top 25 most expensive prescription drugs ranked by average cost per claim from Medicare Part D data.
When Will My Drug Go Generic? Patent Expiry Dates
Patent cliff timeline showing when top brand-name drugs lose exclusivity and generic alternatives become available.
Why Drug Prices Keep Going Up: A Data Breakdown
Drugs with the biggest year-over-year price increases and the systemic reasons behind rising prescription costs.